Budesonide + formoterol delivered via Spiromax® for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler®
Titel:
Budesonide + formoterol delivered via Spiromax® for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler®
Auteur:
Lewis, A. Torvinen, S. Dekhuijzen, P.N.R. Chrystyn, H. Melani, A. Zöllner, Y. Kolbe, K. Watson, A.T. Blackney, M. Plich, A.